Rapid Nutrition PLC (ALRPD.PA)
EUR 0.04
(0.92%)
EUR 0.04
(0.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -293.23 Thousand AUD | -344.54% |
| 2022 | 119.91 Thousand AUD | -94.13% |
| 2021 | 2.04 Million AUD | 43.26% |
| 2020 | 1.42 Million AUD | 0.0% |
| 2018 | 2.33 Million AUD | 43.27% |
| 2017 | 1.62 Million GBP | 14.39% |
| 2016 | 1.42 Million GBP | -27.59% |
| 2015 | 1.96 Million GBP | 59.33% |
| 2014 | 1.23 Million GBP | -8.2% |
| 2013 | 1.34 Million GBP | 24.79% |
| 2012 | 1.07 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | -293.23 Thousand AUD | 24.12% |
| 2023 FY | -293.23 Thousand AUD | -344.54% |
| 2023 Q2 | -830.26 Thousand AUD | 0.0% |
| 2023 Q1 | -830.26 Thousand AUD | -792.4% |
| 2023 Q3 | -386.42 Thousand AUD | 53.46% |
| 2022 FY | 119.91 Thousand AUD | -94.13% |
| 2022 Q4 | 119.91 Thousand AUD | 1982.87% |
| 2022 Q3 | 5757.00 AUD | -95.31% |
| 2022 Q2 | 122.82 Thousand AUD | 0.0% |
| 2022 Q1 | 122.82 Thousand AUD | -93.98% |
| 2021 Q1 | 1.74 Million AUD | 0.0% |
| 2021 Q3 | 1.95 Million AUD | 12.52% |
| 2021 Q4 | 2.04 Million AUD | 4.2% |
| 2021 Q2 | 1.74 Million AUD | 0.0% |
| 2021 FY | 2.04 Million AUD | 43.26% |
| 2020 FY | 1.42 Million AUD | 0.0% |
| 2019 Q1 | 1.69 Million AUD | -4.07% |
| 2019 Q4 | 2.95 Million AUD | 0.0% |
| 2019 Q3 | 2.95 Million AUD | 26.77% |
| 2019 Q2 | 2.33 Million AUD | 37.33% |
| 2018 FY | 2.33 Million AUD | 43.27% |
| 2018 Q4 | 1.77 Million GBP | 0.0% |
| 2018 Q3 | 1.77 Million AUD | 8.75% |
| 2018 Q1 | 1.67 Million AUD | 8.24% |
| 2018 Q2 | 1.62 Million GBP | -2.55% |
| 2017 FY | 1.62 Million GBP | 14.39% |
| 2017 Q3 | 1.52 Million AUD | 6.94% |
| 2017 Q1 | 1.35 Million AUD | -20.93% |
| 2017 Q2 | 1.42 Million GBP | 4.72% |
| 2017 Q4 | 1.54 Million GBP | 1.42% |
| 2016 Q4 | 1.71 Million GBP | 38.85% |
| 2016 Q2 | 1.96 Million GBP | 38.93% |
| 2016 Q1 | 1.41 Million AUD | 15.59% |
| 2016 FY | 1.42 Million GBP | -27.59% |
| 2016 Q3 | 1.23 Million AUD | -37.02% |
| 2015 Q4 | 1.22 Million GBP | 0.0% |
| 2015 Q3 | 1.22 Million AUD | -0.78% |
| 2015 Q2 | 1.23 Million GBP | 1.42% |
| 2015 Q1 | 1.21 Million AUD | 19.51% |
| 2015 FY | 1.96 Million GBP | 59.33% |
| 2014 Q3 | 1.01 Million AUD | -23.34% |
| 2014 Q2 | 1.32 Million AUD | 0.0% |
| 2014 Q4 | 1.01 Million GBP | 0.0% |
| 2014 FY | 1.23 Million GBP | -8.2% |
| 2013 Q2 | 1.05 Million AUD | 0.0% |
| 2013 FY | 1.34 Million GBP | 24.79% |
| 2012 FY | 1.07 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AB Science S.A. | 13.03 Million EUR | 102.25% |
| Boiron SA | -60.34 Million EUR | 99.514% |
| Fagron NV | 233.73 Million EUR | 100.125% |
| Ipsen S.A. | -52.9 Million EUR | 99.446% |
| Malin Corporation plc | -29.2 Million EUR | 98.996% |
| Vetoquinol SA | -129.83 Million EUR | 99.774% |